p300 Suppresses the Transition of Myelodysplastic Syndromes to Acute Myeloid Leukemia

Scientists identified a tumor suppressor role of the acetyltransferase p300 in clinically relevant myelodysplastic syndromes models driven by mutations in the epigenetic regulators TET2, ASXL1, and SRSF2.